 |
Az ESLA-7 génexpressziós mintázat prognosztikai értéke I stádiumú tüdő adenocarcinomában
|
súgó 
nyomtatás 
|
Ezen az oldalon az NKFI Elektronikus Pályázatkezelő Rendszerében nyilvánosságra hozott projektjeit tekintheti meg.
vissza »
|
| |
Közleményjegyzék |
|
|
| Charles Swanton, Dhruva Biswas, Yun-Hsin Liu, Javier Herrero, Yin Wu, David Moore, Takahiro Karasaki, Kristiana Grigoriadis, Wei-Ting Lu, Selvaraju Veeriah, Cristina Naceur-Lombardelli, Neil Magno, Sophia Ward, Alexander Frankell, Mark Hill, Emma Colliver, Sophie de Carne, Philip East, Aman Malhi, Daniel Snell, Olga O'Neill, Daniel Leonce, Johanna Mattsson, Amanda Lindberg, Patrick Micke, Judit Moldvay, Zsolt Megyesfalvi, Balazs Dome, János Fillinger, Jerome Nicod, Julian Downward, Zoltan Szallasi, Allan Hackshaw, Mariam Jamal-Hanjani, Nnennaya Kanu, Nicolai Birkbak, and The TRACERx consortium.: A clonal expression biomarker in patients with lung adenocarcinoma: a prospective observational cohort study., Nature Cancer, accepted for publication, 2024 | | Moldvay J, Tímár J.: KRASG12C mutant lung adenocarcinoma: unique biology, novel therapies and new challenges., Pathol Oncol Res. 2024 Jan 4;29:1611580. doi: 10.3389/pore.2023.1611580., 2024 | | Szeitz B, Glasz T, Herold Z, Tóth G, Balbisi M, Fillinger J, Horváth S, Mohácsi R, Kwon HJ, Moldvay J, Turiák L, Szász AM.: Spatially Resolved Proteomic and Transcriptomic Profiling of Anaplastic Lymphoma Kinase-Rearranged Pulmonary Adenocarcinomas Reveals Key Players in Inter- and Intratumora, Int J Mol Sci. 2023 Jul 12;24(14):11369. doi: 10.3390/ijms241411369., 2023 | | Incze E, Mangó K, Fekete F, Kiss ÁF, Póti Á, Harkó T, Moldvay J,Szüts D, Monostory K.: Potential Association of Cytochrome P450 Copy Number Alteration in Tumour with Chemotherapy Resistance in Lung Adenocarcinoma Patients, Int J Mol Sci 24 : 17 Paper: 13380 , 16 p. (2023), 2023 | | Marton Gyulai, Tunde Harko, Katalin Fabian, Luca Karsko, Laszlo Agocs, Balazs Szigeti, Janos Fillinger, Zoltan Szallasi, Orsolya Pipek and Judit Moldvay: Claudin expression in pulmonary adenoid cystic carcinoma and mucoepidermoid carcinoma, Pathol Oncol Res. 2023 Aug 9. doi: 10.3389/pore.2023.1611328, 2023 | | Gyulai M, Megyesfalvi Z, Reiniger L, Harko T, Ferencz B, Karsko L, Agocs L, Fillinger J, Dome B, Szallasi Z, Moldvay J.: PD-1 and PD-L1 expression in rare lung tumors., Pathol Oncol Res. 2023 May 18;29:1611164. doi: 10.3389/pore.2023.1611164. eCollection 2023., 2023 | | Balbisi M, Sugár S, Schlosser G, Szeitz B, Fillinger J, Moldvay J, Drahos L, Szász AM, Tóth G, Turiák L.: Inter- and intratumoral proteomics and glycosaminoglycan characterization of ALK rearranged lung adenocarcinoma tissues: a pilot study., Sci Rep. 2023 Apr 17;13(1):6268. doi: 10.1038/s41598-023-33435-1., 2023 | | Dora D, Weiss GJ, Megyesfalvi Z, Gállfy G, Dulka E, Kerpel-Fronius A, Berta J, Moldvay J, Dome B, Lohinai Z.: Computed Tomography-Based Quantitative Texture Analysis and Gut Microbial Community Signatures Predict Survival in Non-Small Cell Lung Cancer, Cancers (Basel). 2023 Oct 21;15(20):5091. doi: 10.3390/cancers15205091., 2023 | | Megyesfalvi Z, Barany N, Lantos A, Valko Z, Pipek O, Lang C, Schwendenwein A, Oberndorfer F, Paku S, Ferencz B, Dezso K, Fillinger J, Lohinai Z, Moldvay J, Galffy G, Szeitz B, Rezeli M, Rivard C, Hirsch FR, Brcic L, Popper H, Kern I, Kovacevic M, Skarda J, Mittak M, Marko-Varga G, Bogos K, Renyi-Vamos F, Hoda MA, Klikovits T, Hoetzenecker K, Schelch K, Laszlo V, Dome B.: Expression patterns and prognostic relevance of subtype-specific transcription factors in surgically resected small-cell lung cancer: an international multicenter study., J Pathol. 2022 Aug;257(5):674-686. doi: 10.1002/path.5922. Epub 2022 May 25., 2022 | | Breitenecker K, Homolya M, Luca AC, Lang V, Trenk C, Petroczi G, Mohrherr J, Horvath J, Moritsch S, Haas L, Kurnaeva M, Eferl R, Stoiber D, Moriggl R, Bilban M, Obenauf AC, Ferran C, Dome B, Laszlo V, Győrffy B, Dezso K, Moldvay J, Casanova E, Moll HP.: Down-regulation of A20 promotes immune escape of lung adenocarcinomas., Sci Transl Med. 2021 Jul 7;13(601):eabc3911. doi: 10.1126/scitranslmed.abc3911.PMID: 34233950, 2021 | | Htoo Zarni Oo, Zoltan Lohinai, Nastaran Khazamipour, Joey Lo, Gunjan Kumar, Jessica Pihl, Hans Adomat, Noushin Nabavi, Hakhamanesh Behmanesh, Beibei Zhai, Robert Dagil, Swati Choudhary, Tobias Gustavsson, Thomas M. Clausen, Jeffrey D. Esko, Jeffrey W. Allen, Michael A. Thompson, Nhan L. Tran, Judit Moldvay, Balazs Dome, Ali Salanti, Nader Al-Nakouzi, Glen J. Weiss, Mads Daugaard.: Oncofetal Chondroitin Sulfate Is a Highly Expressed Therapeutic Target in Non-Small Cell Lung Cancer, Cancers 2021, 13, 4489. https://doi.org/10.3390/cancers13174489, 2021 | | Bogos K, Kiss Z, Kerpel Fronius A, Temesi G, Elek J, Madurka I, Cselkó Z, Csányi P, Abonyi-Tóth Z, Rokszin G, Barcza Z, Moldvay J.: Different Trends in Excess Mortality in a Central European Country Compared to Main European Regions in the Year of the COVID-19 Pandemic (2020): a Hungarian Analysis., Pathol Oncol Res. 2021 Apr 13;27:1609774. doi: 10.3389/pore.2021.1609774. eCollection 2021.PMID: 34257618 Free PMC article., 2021 | | Bogos K, Kiss Z, Tamási L, Ostoros G, Müller V, Urbán L, Bittner N, Sárosi V, Vastag A, Polányi Z, Nagy-Erdei Z, Daniel A, Vokó Z, Nagy B, Horváth K, Rokszin G, Abonyi-Tóth Z, Barcza Z, Gálffy G, Moldvay J.: Improvement in Lung Cancer Survival: 6-Year Trends of Overall Survival at Hungarian Patients Diagnosed in 2011-2016., Pathol Oncol Res. 2021 Apr 30;27:603937. doi: 10.3389/pore.2021.603937. eCollection 2021.PMID: 34257563 Free PMC article., 2021 | | Tamási L, Horváth K, Kiss Z, Bogos K, Ostoros G, Müller V, Urbán L, Bittner N, Sárosi V, Vastag A, Polányi Z, Nagy-Erdei Z, Daniel A, Nagy B, Rokszin G, Abonyi-Tóth Z, Moldvay J, Vokó Z, Gálffy G.: Age and Gender Specific Lung Cancer Incidence and Mortality in Hungary: Trends from 2011 Through 2016., Pathol Oncol Res. 2021 Apr 30;27:598862. doi: 10.3389/pore.2021.598862. eCollection 2021.PMID: 34257553 Free PMC article., 2021 | | Sándor GO, Soós AÁ, Lörincz P, Rojkó L, Harkó T, Bogyó L, Tölgyes T, Bursics A, Buzás EI, Moldvay J, Wiener Z.: Wnt Activity and Cell Proliferation Are Coupled to Extracellular Vesicle Release in Multiple Organoid Models., Front Cell Dev Biol. 2021 Jun 24;9:670825. doi: 10.3389/fcell.2021.670825. eCollection 2021.PMID: 34249925 Free PMC article., 2021 | | Radeczky P, Megyesfalvi Z, Laszlo V, Fillinger J, Moldvay J, Raso E, Schlegl E, Barbai T, Timar J, Renyi-Vamos F, Dome B, Hegedus B.: The effects of bisphosphonate and radiation therapy in bone-metastatic lung adenocarcinoma: the impact of KRAS mutation., Transl Lung Cancer Res. 2021 Feb;10(2):675-684. doi: 10.21037/tlcr-20-754.PMID: 33718013 Free PMC article., 2021 | | Gieszer B, Megyesfalvi Z, Dulai V, Papay J, Kovalszky I, Timar J, Fillinger J, Harko T, Pipek O, Teglasi V, Regos E, Papp G, Szallasi Z, Laszlo V, Renyi-Vamos F, Galffy G, Bodor C, Dome B, Moldvay J.: EGFR variant allele frequency predicts EGFR-TKI efficacy in lung adenocarcinoma: a multicenter study., Transl Lung Cancer Res. 2021 Feb;10(2):662-674. doi: 10.21037/tlcr-20-814.PMID: 33718012 Free PMC article., 2021 | | Megyesfalvi Z, Tallosy B, Pipek O, Fillinger J, Lang C, Klikovits T, Schwendenwein A, Hoda MA, Renyi-Vamos F, Laszlo V, Rezeli M, Moldvay J, Dome B.: The landscape of small cell lung cancer metastases: Organ specificity and timing., Thorac Cancer. 2021 Mar;12(6):914-923. doi: 10.1111/1759-7714.13854. Epub 2021 Feb 3.PMID: 33533174, 2021 | | Gálffy G, Vastag A, Bogos K, Kiss Z, Ostoros G, Müller V, Urbán L, Bittner N, Sárosi V, Polányi Z, Nagy-Erdei Z, Daniel A, Knollmajer K, Várnai M, Szegner P, Vokó Z, Nagy B, Horváth K, Rokszin G, Abonyi-Tóth Z, Pozsgai É, Barcza Z, Moldvay J, Tamási L.: Significant Regional Differences in Lung Cancer Incidence in Hungary: Epidemiological Study Between 2011 and 2016, PATHOLOGY AND ONCOLOGY RESEARCH 27 Paper: 1609916, 11 p. (2021), 2021 | | Kiss Z, Bogos K, Tamási L, Ostoros G, Müller V, Urbán L, Bittner N, Sárosi V, Vastag A, Polányi Z, Nagy-Erdei Z, Knollmajer K, Várnai M, Nagy B, Horváth K, Rokszin G, Abonyi-Tóth Z, Barcza Z, Moldvay J, Gálffy G, Vokó Z.: Increase in the Length of Lung Cancer Patient Pathway Before First-Line Therapy : A 6-Year Nationwide Analysis From Hungary, PATHOLOGY AND ONCOLOGY RESEARCH 27 Paper: 1610041, 11 p. (2021), 2021 | | Ni Y, Lohinai Z, Heshiki Y, Dome B, Moldvay J, Dulka E, Galffy G, Berta J, Weiss GJ, Sommer MOA, Panagiotou G.: Distinct composition and metabolic functions of human gut microbiota are associated with cachexia in lung cancer patients, ISME JOURNAL 15: 11 pp. 3207-3220. , 14 p. (2021), 2021 | | Radeczky P, Moldvay J, Fillinger J, Szeitz B, Ferencz B, Boettiger K, Rezeli M, Bogos K, Renyi-Vamos F, Hoetzenecker K, Hegedus B, Megyesfalvi Z, Dome B.: Bone-Specific Metastasis Pattern of Advanced-Stage Lung Adenocarcinoma According to the Localization of the Primary Tumor, PATHOLOGY AND ONCOLOGY RESEARCH 27 Paper: 1609926, 10 p. (2021), 2021 | | Bogos K, Kiss Z, Gálffy G, Tamási L, Ostoros G, Müller V, Urbán L, Bittner N, Sárosi V, Vastag A, Polányi Z, Nagy-Erdei Z, Vokó Z, Nagy B, Horváth K, Rokszin G, Abonyi-Tóth Z, Barcza Z, Moldvay J.: Lung Cancer in Hungary, Journal of Thoracic Oncology. 2020 May;15(5):692-699., 2020 | | Biswas D, Birkbak NJ, Rosenthal R, Hiley CT, Lim EL, Papp K, Boeing S, Krzystanek M, Djureinovic D, La Fleur L, Greco M, Döme B, Fillinger J, Brunnström H, Wu Y, Moore DA, Skrzypski M, Abbosh C, Litchfield K, Al Bakir M, Watkins TBK, Veeriah S, Wilson GA, Jamal-Hanjani M, Moldvay J, Botling J, Chinnaiyan AM, Micke P, Hackshaw A, Bartek J, Csabai I, Szallasi Z, Herrero J, McGranahan N, Swanton C; TRACERx Consortium.: A clonal expression biomarker associates with lung cancer mortality, Nature Medicine. 2019 Oct;25(10):1540-1548., 2019 | | Ghimessy AK, Gellert A, Schlegl E, Hegedus B, Raso E, Barbai T, Timar J, Ostoros G, Megyesfalvi Z, Gieszer B, Moldvay J, Renyi-Vamos F, Lohinai Z, Hoda MA, Klikovits T, Klepetko W, Laszlo V, Dome B.: KRAS Mutations Predict Response and Outcome in Advanced Lung Adenocarcinoma Patients Receiving First-Line Bevacizumab and Platinum-Based Chemotherapy., Cancers (Basel). 2019 Oct 9;11(10):1514., 2019 | | Lohinai Z, Megyesfalvi Z, Suda K, Harko T, Ren S, Moldvay J, Laszlo V, Rivard C, Dome B, Hirsch FR.: Comparative expression analysis in small cell lung carcinoma reveals neuroendocrine pattern change in primary tumor versus lymph node metastases., Translational Lung Cancer Research. 2019 Dec;8(6):938-950., 2019 | | Bogos K, Kiss Z, Gálffy G, Tamási L, Ostoros G, Müller V, Urbán L, Bittner N, Sárosi V, Vastag A, Polányi Z, Nagy-Erdei Z, Vokó Z, Nagy B, Horváth K, Rokszin G, Abonyi-Tóth Z, Moldvay J.: Revising Incidence and Mortality of Lung Cancer in Central Europe: An Epidemiology Review From Hungary., Frontiers in Oncology. 2019 Oct 23;9:1051., 2019 | | Bogos K, Kiss Z, Gálffy G, Tamási L, Ostoros G, Müller V, Urbán L, Bittner N, Sárosi V, Vastag A, Polányi Z, Nagy-Erdei Z, Vokó Z, Nagy B, Horváth K, Rokszin G, Abonyi-Tóth Z, Barcza Z, Moldvay J.: Lung Cancer in Hungary, Journal of Thoracic Oncology. 2020 May;15(5):692-699., 2020 | | Reiniger L, Téglási V, Pipek O, Rojkó L, Glasz T, Vágvölgyi A, Kovalszky I, Gyulai M, Lohinai Z, Rásó E, Tímár J, Döme B, Szállási Z, Moldvay J.: Tumor necrosis correlates with PD-L1 and PD-1 expression in lung adenocarcinoma., Acta Oncol. 2019 Aug;58(8):1087-1094., 2019 | | Téglási V, Pipek O, Lózsa R, Berta K, Szüts D, Harkó T, Vadász P, Rojkó L, Döme B, Bagó AG, Tímár J, Moldvay J, Szállási Z, Reiniger L.: PD-L1 Expression of Lung Cancer Cells, Unlike Infiltrating Immune Cells, Is Stable and Unaffected by Therapy During Brain Metastasis., Clin Lung Cancer. 2019 Sep;20(5):363-369., 2019 | | Htoo Zarni Oo, Zoltan Lohinai, Nastaran Khazamipour, Joey Lo, Gunjan Kumar, Jessica Pihl, Hans Adomat, Noushin Nabavi, Hakhamanesh Behmanesh, Beibei Zhai, Robert Dagil, Swati Choudhary, Tobias Gustavsson, Thomas M. Clausen, Jeffrey D. Esko, Jeffrey W. Allen, Michael A. Thompson, Nhan L. Tran, Judit Moldvay, Balazs Dome, Ali Salanti, Nader Al-Nakouzi, Glen J. Weiss, Mads Daugaard.: Oncofetal Chondroitin Sulfate Is a Highly Expressed Therapeutic Target in Non-Small Cell Lung Cancer, Cancers 2021, 13, 4489. https://doi.org/10.3390/cancers13174489, 2021 | | Bogos K, Kiss Z, Kerpel Fronius A, Temesi G, Elek J, Madurka I, Cselkó Z, Csányi P, Abonyi-Tóth Z, Rokszin G, Barcza Z, Moldvay J.: Different Trends in Excess Mortality in a Central European Country Compared to Main European Regions in the Year of the COVID-19 Pandemic (2020): a Hungarian Analysis., Pathol Oncol Res. 2021 Apr 13;27:1609774. doi: 10.3389/pore.2021.1609774. eCollection 2021.PMID: 34257618 Free PMC article., 2021 | | Bogos K, Kiss Z, Tamási L, Ostoros G, Müller V, Urbán L, Bittner N, Sárosi V, Vastag A, Polányi Z, Nagy-Erdei Z, Daniel A, Vokó Z, Nagy B, Horváth K, Rokszin G, Abonyi-Tóth Z, Barcza Z, Gálffy G, Moldvay J.: Improvement in Lung Cancer Survival: 6-Year Trends of Overall Survival at Hungarian Patients Diagnosed in 2011-2016., Pathol Oncol Res. 2021 Apr 30;27:603937. doi: 10.3389/pore.2021.603937. eCollection 2021.PMID: 34257563 Free PMC article., 2021 | | Tamási L, Horváth K, Kiss Z, Bogos K, Ostoros G, Müller V, Urbán L, Bittner N, Sárosi V, Vastag A, Polányi Z, Nagy-Erdei Z, Daniel A, Nagy B, Rokszin G, Abonyi-Tóth Z, Moldvay J, Vokó Z, Gálffy G.: Age and Gender Specific Lung Cancer Incidence and Mortality in Hungary: Trends from 2011 Through 2016., Pathol Oncol Res. 2021 Apr 30;27:598862. doi: 10.3389/pore.2021.598862. eCollection 2021.PMID: 34257553 Free PMC article., 2021 | | Sándor GO, Soós AÁ, Lörincz P, Rojkó L, Harkó T, Bogyó L, Tölgyes T, Bursics A, Buzás EI, Moldvay J, Wiener Z.: Wnt Activity and Cell Proliferation Are Coupled to Extracellular Vesicle Release in Multiple Organoid Models., Front Cell Dev Biol. 2021 Jun 24;9:670825. doi: 10.3389/fcell.2021.670825. eCollection 2021.PMID: 34249925 Free PMC article., 2021 | | Breitenecker K, Homolya M, Luca AC, Lang V, Trenk C, Petroczi G, Mohrherr J, Horvath J, Moritsch S, Haas L, Kurnaeva M, Eferl R, Stoiber D, Moriggl R, Bilban M, Obenauf AC, Ferran C, Dome B, Laszlo V, Győrffy B, Dezso K, Moldvay J, Casanova E, Moll HP.: Down-regulation of A20 promotes immune escape of lung adenocarcinomas., Sci Transl Med. 2021 Jul 7;13(601):eabc3911. doi: 10.1126/scitranslmed.abc3911.PMID: 34233950, 2021 | | Radeczky P, Megyesfalvi Z, Laszlo V, Fillinger J, Moldvay J, Raso E, Schlegl E, Barbai T, Timar J, Renyi-Vamos F, Dome B, Hegedus B.: The effects of bisphosphonate and radiation therapy in bone-metastatic lung adenocarcinoma: the impact of KRAS mutation., Transl Lung Cancer Res. 2021 Feb;10(2):675-684. doi: 10.21037/tlcr-20-754.PMID: 33718013 Free PMC article., 2021 | | Gieszer B, Megyesfalvi Z, Dulai V, Papay J, Kovalszky I, Timar J, Fillinger J, Harko T, Pipek O, Teglasi V, Regos E, Papp G, Szallasi Z, Laszlo V, Renyi-Vamos F, Galffy G, Bodor C, Dome B, Moldvay J.: EGFR variant allele frequency predicts EGFR-TKI efficacy in lung adenocarcinoma: a multicenter study., Transl Lung Cancer Res. 2021 Feb;10(2):662-674. doi: 10.21037/tlcr-20-814.PMID: 33718012 Free PMC article., 2021 | | Megyesfalvi Z, Tallosy B, Pipek O, Fillinger J, Lang C, Klikovits T, Schwendenwein A, Hoda MA, Renyi-Vamos F, Laszlo V, Rezeli M, Moldvay J, Dome B.: The landscape of small cell lung cancer metastases: Organ specificity and timing., Thorac Cancer. 2021 Mar;12(6):914-923. doi: 10.1111/1759-7714.13854. Epub 2021 Feb 3.PMID: 33533174, 2021 | | Rojko L, Megyesfalvi Z, Czibula E, Reiniger L, Teglasi V, Szegedi Z, Szallasi Z, Dome B, Moldvay J.: Longitudinal analysis of complete blood count parameters in advanced-stage lung cancer patients., Thorac Cancer. 2020 Nov;11(11):3193-3204. doi: 10.1111/1759-7714.13642. Epub 2020 Sep 17.PMID: 32941706 Free PMC article., 2020 | | Dora D, Rivard C, Yu H, Bunn P, Suda K, Ren S, Lueke Pickard S, Laszlo V, Harko T, Megyesfalvi Z, Moldvay J, Hirsch FR, Dome B, Lohinai Z.: Neuroendocrine subtypes of small cell lung cancer differ in terms of immune microenvironment and checkpoint molecule distribution., Mol Oncol. 2020 Sep;14(9):1947-1965. doi: 10.1002/1878-0261.12741. Epub 2020 Jul 18.PMID: 32506804 Free PMC article., 2020 | | Htoo Zarni Oo, Zoltan Lohinai, Nastaran Khazamipour, Joey Lo, Gunjan Kumar, Jessica Pihl, Hans Adomat, Noushin Nabavi, Hakhamanesh Behmanesh, Beibei Zhai, Robert Dagil, Swati Choudhary, Tobias Gustavsson, Thomas M. Clausen, Jeffrey D. Esko, Jeffrey W. Allen, Michael A. Thompson, Nhan L. Tran, Judit Moldvay, Balazs Dome, Ali Salanti, Nader Al-Nakouzi, Glen J. Weiss, Mads Daugaard.: Oncofetal Chondroitin Sulfate Is a Highly Expressed Therapeutic Target in Non-Small Cell Lung Cancer, Cancers 2021, 13, 4489. https://doi.org/10.3390/cancers13174489, 2021 | | Bogos K, Kiss Z, Kerpel Fronius A, Temesi G, Elek J, Madurka I, Cselkó Z, Csányi P, Abonyi-Tóth Z, Rokszin G, Barcza Z, Moldvay J.: Different Trends in Excess Mortality in a Central European Country Compared to Main European Regions in the Year of the COVID-19 Pandemic (2020): a Hungarian Analysis., Pathol Oncol Res. 2021 Apr 13;27:1609774. doi: 10.3389/pore.2021.1609774. eCollection 2021.PMID: 34257618 Free PMC article., 2021 | | Bogos K, Kiss Z, Tamási L, Ostoros G, Müller V, Urbán L, Bittner N, Sárosi V, Vastag A, Polányi Z, Nagy-Erdei Z, Daniel A, Vokó Z, Nagy B, Horváth K, Rokszin G, Abonyi-Tóth Z, Barcza Z, Gálffy G, Moldvay J.: Improvement in Lung Cancer Survival: 6-Year Trends of Overall Survival at Hungarian Patients Diagnosed in 2011-2016., Pathol Oncol Res. 2021 Apr 30;27:603937. doi: 10.3389/pore.2021.603937. eCollection 2021.PMID: 34257563 Free PMC article., 2021 | | Tamási L, Horváth K, Kiss Z, Bogos K, Ostoros G, Müller V, Urbán L, Bittner N, Sárosi V, Vastag A, Polányi Z, Nagy-Erdei Z, Daniel A, Nagy B, Rokszin G, Abonyi-Tóth Z, Moldvay J, Vokó Z, Gálffy G.: Age and Gender Specific Lung Cancer Incidence and Mortality in Hungary: Trends from 2011 Through 2016., Pathol Oncol Res. 2021 Apr 30;27:598862. doi: 10.3389/pore.2021.598862. eCollection 2021.PMID: 34257553 Free PMC article., 2021 | | Sándor GO, Soós AÁ, Lörincz P, Rojkó L, Harkó T, Bogyó L, Tölgyes T, Bursics A, Buzás EI, Moldvay J, Wiener Z.: Wnt Activity and Cell Proliferation Are Coupled to Extracellular Vesicle Release in Multiple Organoid Models., Front Cell Dev Biol. 2021 Jun 24;9:670825. doi: 10.3389/fcell.2021.670825. eCollection 2021.PMID: 34249925 Free PMC article., 2021 | | Radeczky P, Megyesfalvi Z, Laszlo V, Fillinger J, Moldvay J, Raso E, Schlegl E, Barbai T, Timar J, Renyi-Vamos F, Dome B, Hegedus B.: The effects of bisphosphonate and radiation therapy in bone-metastatic lung adenocarcinoma: the impact of KRAS mutation., Transl Lung Cancer Res. 2021 Feb;10(2):675-684. doi: 10.21037/tlcr-20-754.PMID: 33718013 Free PMC article., 2021 | | Gieszer B, Megyesfalvi Z, Dulai V, Papay J, Kovalszky I, Timar J, Fillinger J, Harko T, Pipek O, Teglasi V, Regos E, Papp G, Szallasi Z, Laszlo V, Renyi-Vamos F, Galffy G, Bodor C, Dome B, Moldvay J.: EGFR variant allele frequency predicts EGFR-TKI efficacy in lung adenocarcinoma: a multicenter study., Transl Lung Cancer Res. 2021 Feb;10(2):662-674. doi: 10.21037/tlcr-20-814.PMID: 33718012 Free PMC article., 2021 | | Megyesfalvi Z, Tallosy B, Pipek O, Fillinger J, Lang C, Klikovits T, Schwendenwein A, Hoda MA, Renyi-Vamos F, Laszlo V, Rezeli M, Moldvay J, Dome B.: The landscape of small cell lung cancer metastases: Organ specificity and timing., Thorac Cancer. 2021 Mar;12(6):914-923. doi: 10.1111/1759-7714.13854. Epub 2021 Feb 3.PMID: 33533174, 2021 | | Rojko L, Megyesfalvi Z, Czibula E, Reiniger L, Teglasi V, Szegedi Z, Szallasi Z, Dome B, Moldvay J.: Longitudinal analysis of complete blood count parameters in advanced-stage lung cancer patients., Thorac Cancer. 2020 Nov;11(11):3193-3204. doi: 10.1111/1759-7714.13642. Epub 2020 Sep 17.PMID: 32941706 Free PMC article., 2020 | | Dora D, Rivard C, Yu H, Bunn P, Suda K, Ren S, Lueke Pickard S, Laszlo V, Harko T, Megyesfalvi Z, Moldvay J, Hirsch FR, Dome B, Lohinai Z.: Neuroendocrine subtypes of small cell lung cancer differ in terms of immune microenvironment and checkpoint molecule distribution., Mol Oncol. 2020 Sep;14(9):1947-1965. doi: 10.1002/1878-0261.12741. Epub 2020 Jul 18.PMID: 32506804 Free PMC article., 2020 | | Megyesfalvi Z, Barany N, Lantos A, Valko Z, Pipek O, Lang C, Schwendenwein A, Oberndorfer F, Paku S, Ferencz B, Dezso K, Fillinger J, Lohinai Z, Moldvay J, Galffy G, Szeitz B, Rezeli M, Rivard C, Hirsch FR, Brcic L, Popper H, Kern I, Kovacevic M, Skarda J, Mittak M, Marko-Varga G, Bogos K, Renyi-Vamos F, Hoda MA, Klikovits T, Hoetzenecker K, Schelch K, Laszlo V, Dome B.: Expression patterns and prognostic relevance of subtype-specific transcription factors in surgically resected small cell lung cancer: an international multicenter study., JOURNAL OF PATHOLOGY 257: 5 pp. 674-686., 13 p. (2022), 2022 | | Gálffy G, Vastag A, Bogos K, Kiss Z, Ostoros G, Müller V, Urbán L, Bittner N, Sárosi V, Polányi Z, Nagy-Erdei Z, Daniel A, Knollmajer K, Várnai M, Szegner P, Vokó Z, Nagy B, Horváth K, Rokszin G, Abonyi-Tóth Z, Pozsgai É, Barcza Z, Moldvay J, Tamási L.: Significant Regional Differences in Lung Cancer Incidence in Hungary: Epidemiological Study Between 2011 and 2016, PATHOLOGY AND ONCOLOGY RESEARCH 27 Paper: 1609916, 11 p. (2021), 2021 | | Kiss Z, Bogos K, Tamási L, Ostoros G, Müller V, Urbán L, Bittner N, Sárosi V, Vastag A, Polányi Z, Nagy-Erdei Z, Knollmajer K, Várnai M, Nagy B, Horváth K, Rokszin G, Abonyi-Tóth Z, Barcza Z, Moldvay J, Gálffy G, Vokó Z.: Increase in the Length of Lung Cancer Patient Pathway Before First-Line Therapy : A 6-Year Nationwide Analysis From Hungary, PATHOLOGY AND ONCOLOGY RESEARCH 27 Paper: 1610041, 11 p. (2021), 2021 | | Ni Y, Lohinai Z, Heshiki Y, Dome B, Moldvay J, Dulka E, Galffy G, Berta J, Weiss GJ, Sommer MOA, Panagiotou G.: Distinct composition and metabolic functions of human gut microbiota are associated with cachexia in lung cancer patients, ISME JOURNAL 15: 11 pp. 3207-3220. , 14 p. (2021), 2021 | | Radeczky P, Moldvay J, Fillinger J, Szeitz B, Ferencz B, Boettiger K, Rezeli M, Bogos K, Renyi-Vamos F, Hoetzenecker K, Hegedus B, Megyesfalvi Z, Dome B.: Bone-Specific Metastasis Pattern of Advanced-Stage Lung Adenocarcinoma According to the Localization of the Primary Tumor, PATHOLOGY AND ONCOLOGY RESEARCH 27 Paper: 1609926, 10 p. (2021), 2021 | | Incze E, Mangó K, Fekete F, Kiss ÁF, Póti Á, Harkó T, Moldvay J,Szüts D, Monostory K.: Potential Association of Cytochrome P450 Copy Number Alteration in Tumour with Chemotherapy Resistance in Lung Adenocarcinoma Patients, Int J Mol Sci 24 : 17 Paper: 13380 , 16 p. (2023), 2023 | | Marton Gyulai, Tunde Harko, Katalin Fabian, Luca Karsko, Laszlo Agocs, Balazs Szigeti, Janos Fillinger, Zoltan Szallasi, Orsolya Pipek and Judit Moldvay: Claudin expression in pulmonary adenoid cystic carcinoma and mucoepidermoid carcinoma, Pathol Oncol Res. 2023 Aug 9. doi: 10.3389/pore.2023.1611328, 2023 | | Szeitz B, Glasz T, Herold Z, Tóth G, Balbisi M, Fillinger J, Horváth S, Mohácsi R, Kwon HJ, Moldvay J, Turiák L, Szász AM.: Spatially Resolved Proteomic and Transcriptomic Profiling of Anaplastic Lymphoma Kinase-Rearranged Pulmonary Adenocarcinomas Reveals Key Players in Inter- and Intratumora, Int J Mol Sci. 2023 Jul 12;24(14):11369. doi: 10.3390/ijms241411369., 2023 | | Gyulai M, Megyesfalvi Z, Reiniger L, Harko T, Ferencz B, Karsko L, Agocs L, Fillinger J, Dome B, Szallasi Z, Moldvay J.: PD-1 and PD-L1 expression in rare lung tumors., Pathol Oncol Res. 2023 May 18;29:1611164. doi: 10.3389/pore.2023.1611164. eCollection 2023., 2023 | | Balbisi M, Sugár S, Schlosser G, Szeitz B, Fillinger J, Moldvay J, Drahos L, Szász AM, Tóth G, Turiák L.: Inter- and intratumoral proteomics and glycosaminoglycan characterization of ALK rearranged lung adenocarcinoma tissues: a pilot study., Sci Rep. 2023 Apr 17;13(1):6268. doi: 10.1038/s41598-023-33435-1., 2023 | | Woldmar N, Schwendenwein A, Kuras M, Szeitz B, Boettiger K, Tisza A, László V, Reiniger L, Bagó AG, Szállási Z, Moldvay J, Szász AM, Malm J, Horvatovich P, Pizzatti L, Domont GB, Rényi-Vámos F, Hoetzenecker K, Hoda MA, Marko-Varga G, Schelch K, Megyesfalvi Z, Rezeli M, Döme B.: Proteomic analysis of brain metastatic lung adenocarcinoma reveals intertumoral heterogeneity and specific alterations associated with the timing of brain metastases., ESMO Open. 2023 Feb;8(1):100741. doi: 10.1016/j.esmoop.2022.100741. Epub 2022 Dec 16., 2023 | | Megyesfalvi Z, Barany N, Lantos A, Valko Z, Pipek O, Lang C, Schwendenwein A, Oberndorfer F, Paku S, Ferencz B, Dezso K, Fillinger J, Lohinai Z, Moldvay J, Galffy G, Szeitz B, Rezeli M, Rivard C, Hirsch FR, Brcic L, Popper H, Kern I, Kovacevic M, Skarda J, Mittak M, Marko-Varga G, Bogos K, Renyi-Vamos F, Hoda MA, Klikovits T, Hoetzenecker K, Schelch K, Laszlo V, Dome B.: Expression patterns and prognostic relevance of subtype-specific transcription factors in surgically resected small-cell lung cancer: an international multicenter study., J Pathol. 2022 Aug;257(5):674-686. doi: 10.1002/path.5922. Epub 2022 May 25., 2022 | | Biswas D, Birkbak NJ, Rosenthal R, Hiley CT, Lim EL, Papp K, Boeing S, Krzystanek M, Djureinovic D, La Fleur L, Greco M, Döme B, Fillinger J, Brunnström H, Wu Y, Moore DA, Skrzypski M, Abbosh C, Litchfield K, Al Bakir M, Watkins TBK, Veeriah S, Wilson GA, Jamal-Hanjani M, Moldvay J, Botling J, Chinnaiyan AM, Micke P, Hackshaw A, Bartek J, Csabai I, Szallasi Z, Herrero J, McGranahan N, Swanton C; TRACERx Consortium.: A clonal expression biomarker associates with lung cancer mortality, Nature Medicine. 2019 Oct;25(10):1540-1548., 2019 |
|
|
|
|
|
|
|
|
|
